Condividi
Fr. 99.00
John R. (EDT) White, John R. White
2023-24 Guide to Medications for the Treatment of Diabetes Mellitus
Inglese · Tascabile
Pubblicazione il 22.08.2023
Descrizione
The 2023-24 Guide to Medications for the Treatment of Diabetes Mellitus is a complete, up-to-date reference for every physician, clinician, and educator treating people with diabetes. Compiled and edited by a team of noted pharmacology experts specializing in diabetes care, this guide covers all aspects of diabetes drug classes including insulins, biguanides, thiazolidinediones, sulfonylureas, glinides, SGLT2 inhibitors, α-glucosidase inhibitors, DPP-4 inhibitors, GLP-1 RAs, pramlintide, bile acid sequestrants, and dopamine-2 RAs. Chapters cover the management of hyperglycemia in type 1 diabetes and an overview of medications used to treat type 2 diabetes.
This guide also includes chapters on medications to manage comorbidities such as:
• Neuropathy
• Nephropathy
• Retinopathy
• Hypoglycemia
• Obesity
• Depression
Sommario
1. Pharmacologic Therapy for Type 1 Diabetes 1
2. Management of Hyperglycemia in Type 1 Diabetes Mellitus 15
Joshua J. Neumiller, PharmD, CDE, FADCES, FASCP
3. Insulin 34
Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP, and
Kimberly C. McKeirnan, PharmD, BCACP
4. Pharmacologic Therapy for Type 2 Diabetes 56
5. Overview of Medications Used to Treat Type 2 Diabetes 79
John R. White, Jr., PA-C, PharmD
6. Biguanides 94
Peggy Soule Odegard, BSPharm, PharmD, CDCES, and
Kam L. Capoccia, PharmD, BCPS, CDCES
7. Thiazolidinediones 123
Kam L. Capoccia, PharmD, BCPS, CDCES, and
Peggy Soule Odegard, BSPharm, PharmD, CDCES
8. Sulfonylureas 145
Lisa Kroon, PharmD, and Crystal Zhou, PharmD
9. Glinides 160
Lisa Kroon, PharmD, and Crystal Zhou, PharmD
10. SGLT2 Inhibitors 172
John R. White, Jr., PA-C, PharmD
11. α-Glucosidase Inhibitors 190
Kimberly C. McKeirnan, PharmD, BCACP, and
Nicole M. Rodin, PharmD, MBA
12. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors 198
Kimberly C. McKeirnan, PharmD, BCACP,
and Joshua J. Neumiller, PharmD, CDE, FADCES, FASCP
13. Glucagon-Like Peptide-1 Receptor Agonists 213
Jennifer M. Trujillo, PharmD, BCPS, FCCP, CDCES, BC-ADM
14. Pramlintide 238
Jennifer M. Trujillo, PharmD, BCPS, FCCP, CDCES, BC-ADM
15. Bile Acid Sequestrants 250
Christina R. Buchman, PharmD, BCACP
16. Dopamine-2 Receptor Agonists 260
Christina R. Buchman, PharmD, BCACP
17. Cardiovascular Disease and Risk Management 267
18. Chronic Kidney Disease and Risk Management 337
19. Retinopathy, Neuropathy, and Foot Care 362
20. Hypertension 390
Cheyenne Frazier, PharmD, PhC, BCACP
21. Lipids 407
Cheyenne Frazier, PharmD, PhC, BCACP
22. Antiplatelets 425
Megan Willson, PharmD, BCPS, and
Kimberly C. McKeirnan, PharmD, BCACP
23. Medications for Smoking Cessation 441
Anne P. Kim, PharmD, MPH, MIT
24. Medications for the Management of Neuropathy 466
Damianne Brand-Eubanks, PharmD
25. Medications for the Management of Nephropathy 483
Emmeline Tran, PharmD
26. Medications for the Management of Retinopathy 516
Emmeline Tran, PharmD
27. Medications for the Management of Depression 540
Megan Willson, PharmD, BCPS
28. Medications for the Management of Hypoglycemia 552
Megan Giruzzi, PharmD, BCPS
29. Medications for the Management of Obesity 565
Nicholas R. Giruzzi, PharmD, BCPS
30. Immunizations and Diabetes 594
Kimberly C. McKeirnan, PharmD, BCACP, and
Nicole M. Rodin, PharmD, MBA
Index 602
Info autore
John R. White, Jr., PA-C, PharmD, is Chair and the R. Keith Campbell Distinguished Professor in Diabetes Care of the Department of Pharmacotherapy at the Washington State University College of Pharmacy. Dr. White is the author of three books, over 30 book chapters, and more than 150 manuscripts on diabetes medications. In addition to his teaching responsibilities at the university, he is a sought-after speaker and has given over 330 lectures at domestic and international conferences. He has been on the editorial boards of many diabetes-related scholarly journals and is currently Associate Editor of Clinical Diabetes.
Riassunto
The 2023-24 Guide to Medications for the Treatment of Diabetes Mellitus is a complete, up-to-date reference for every physician, clinician, and educator treating people with diabetes. Compiled and edited by a team of noted pharmacology experts specializing in diabetes care, this guide covers all aspects of diabetes drug classes including insulins, biguanides, thiazolidinediones, sulfonylureas, glinides, SGLT2 inhibitors, α-glucosidase inhibitors, DPP-4 inhibitors, GLP-1 RAs, pramlintide, bile acid sequestrants, and dopamine-2 RAs. Chapters cover the management of hyperglycemia in type 1 diabetes and an overview of medications used to treat type 2 diabetes.
Dettagli sul prodotto
Autori | John R. (EDT) White |
Con la collaborazione di | John R. White (Editore) |
Editore | American diabetes association |
Lingue | Inglese |
Formato | Tascabile |
Pubblicazione | 22.08.2023, ritardato |
EAN | 9781580407649 |
ISBN | 978-1-58040-764-9 |
Pagine | 658 |
Dimensioni | 146 mm x 222 mm x 38 mm |
Categorie |
Guide e manuali
> Mangiare e bere
> Cucina sana, cucina salutistica
MEDICAL / Clinical Medicine, MEDICAL / Pharmacology, MEDICAL / Education & Training, HEALTH & FITNESS / Diseases & Conditions / Diabetes |
Recensioni dei clienti
Per questo articolo non c'è ancora nessuna recensione. Scrivi la prima recensione e aiuta gli altri utenti a scegliere.
Scrivi una recensione
Top o flop? Scrivi la tua recensione.